Payments to Acquire Property, Plant, and Equipment of Keenova Therapeutics plc from 30 Sep 2011 to 28 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Keenova Therapeutics plc quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Sep 2011 to 28 Mar 2025.
  • Keenova Therapeutics plc Payments to Acquire Property, Plant, and Equipment for the quarter ending 28 Mar 2025 was $24,300,000, a 1.2% decline year-over-year.
  • Keenova Therapeutics plc annual Payments to Acquire Property, Plant, and Equipment for 2024 was $113,200,000.
  • Keenova Therapeutics plc annual Payments to Acquire Property, Plant, and Equipment for 2021 was $55,300,000, a 16% increase from 2020.
  • Keenova Therapeutics plc annual Payments to Acquire Property, Plant, and Equipment for 2020 was $47,700,000, a 64% decline from 2019.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Keenova Therapeutics plc Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $24,300,000 -$300,000 -1.2% 28 Dec 2024 28 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $24,600,000 +$5,300,000 +27% 30 Dec 2023 29 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $8,500,000 15 Nov 2023 29 Dec 2023 10-K 13 Mar 2025 2024 FY
Q1 2023 $19,300,000 -$4,300,000 -18% 31 Dec 2022 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2022 $15,600,000 17 Jun 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $3,700,000 17 Jun 2022 01 Jul 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $23,600,000 +$2,700,000 +13% 01 Jan 2022 01 Apr 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $20,900,000 +$1,000,000 +5% 26 Dec 2020 26 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $19,900,000 -$19,900,000 -50% 28 Dec 2019 27 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $39,800,000 +$5,500,000 +16% 29 Dec 2018 29 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $34,300,000 -$18,300,000 -35% 30 Dec 2017 30 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $52,600,000 +$10,200,000 +24% 31 Dec 2016 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $65,200,000 +$16,200,000 +33% 01 Oct 2016 30 Dec 2016 10-K 26 Feb 2019 2018 FY
Q1 2016 $42,400,000 26 Dec 2015 25 Mar 2016 10-Q 08 May 2017 2017 Q1
Q4 2015 $49,000,000 +$26,700,000 +120% 26 Sep 2015 25 Dec 2015 10-K 26 Feb 2019 2018 FY
Q4 2014 $22,300,000 +$600,000 +2.8% 27 Sep 2014 26 Dec 2014 10-Q 02 Feb 2016 2016 Q1
Q4 2013 $21,700,000 -$21,100,000 -49% 28 Sep 2013 27 Dec 2013 10-Q 03 Feb 2015 2015 Q1
Q4 2012 $42,800,000 29 Sep 2012 28 Dec 2012 10-Q 07 Feb 2014 2014 Q1

Keenova Therapeutics plc Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $113,200,000 30 Dec 2023 27 Dec 2024 10-K 13 Mar 2025 2024 FY
2021 $55,300,000 +$7,600,000 +16% 26 Dec 2020 31 Dec 2021 10-K 26 Mar 2024 2023 FY
2020 $47,700,000 -$85,300,000 -64% 28 Dec 2019 25 Dec 2020 10-K 03 Mar 2023 2022 FY
2019 $133,000,000 +$6,000,000 +4.7% 29 Dec 2018 27 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $127,000,000 -$59,100,000 -32% 30 Dec 2017 28 Dec 2018 10-K 10 Mar 2021 2020 FY
2017 $186,100,000 +$3,200,000 +1.8% 31 Dec 2016 29 Dec 2017 10-K 26 Feb 2020 2019 FY
2016 $182,900,000 +$34,900,000 +24% 26 Sep 2015 30 Sep 2016 10-K 26 Feb 2019 2018 FY
2015 $148,000,000 +$20,200,000 +16% 27 Sep 2014 25 Sep 2015 10-K 27 Feb 2018 2017 FY
2014 $127,800,000 -$20,100,000 -14% 28 Sep 2013 26 Sep 2014 10-K 29 Nov 2016 2016 FY
2013 $147,900,000 +$3,700,000 +2.6% 29 Sep 2012 27 Sep 2013 10-K 24 Nov 2015 2015 FY
2012 $144,200,000 +$23,800,000 +20% 01 Oct 2011 28 Sep 2012 8-K 03 Apr 2015 2014 FY
2011 $120,400,000 25 Sep 2010 30 Sep 2011 10-K 13 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.